India to Taiwan: Pazopanib Export Trade Route

The India to Taiwan Pazopanib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $192.9K USD. The route is dominated by CBCC GLOBAL RESEARCH LLP , which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's pazopanib manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $96.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with pazopanib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 11.6%, placing it at rank #11 among India's top pazopanib export destinations globally.

On the import side, key buyers of Indian pazopanib in Taiwan include LOTUS PHARMACEUTICAL CO.LTD., . LOTUS PHARMACEUTICAL CO.LTD., is the single largest importer with 2 shipments valued at $192.9K USD.

India's pazopanib exports to Taiwan are driven primarily by a handful of large-scale manufacturers. CBCC GLOBAL RESEARCH LLP with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Taiwan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CBCC GLOBAL RESEARCH LLP — together account for 100% of total trade value on this route. The average shipment value of $96.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pazopanib hcl 200mg tablets 01 bottle co , suggesting that buyers in Taiwan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LOTUS PHARMACEUTICAL CO.LTD., is the largest importer with 2 shipments worth $192.9K USD — representing 100% of all pazopanib imports from India on this route.